We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+14.31%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$16.1B
AUM Growth
+$2.04B
Cap. Flow
-$98.3M
Cap. Flow %
-0.61%
Top 10 Hldgs %
35.04%
Holding
1,426
New
99
Increased
660
Reduced
349
Closed
106

Top Buys

Rank Stock Value
1
IRM icon
Iron Mountain
IRM
+$97M
2
VICI icon
VICI Properties
VICI
+$80.3M
3
ESS icon
Essex Property Trust
ESS
+$78.8M
4
WPC icon
W.P. Carey
WPC
+$61.7M
5
IBN icon
ICICI Bank
IBN
+$28M

Sector Composition

Rank Sector Weight
1 Real Estate 52.1%
2 Technology 13.53%
3 Consumer Discretionary 4.91%
4 Financials 4.82%
5 Healthcare 4.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVAC
1226
DELISTED
CureVac
CVAC
$3K ﹤0.01%
697
DYN icon
1227
Dyne Therapeutics
DYN
$4.28B
$3K ﹤0.01%
210
EWTX icon
1228
Edgewise Therapeutics
EWTX
$4.34B
$3K ﹤0.01%
254
EYPT icon
1229
EyePoint Inc
EYPT
$1B
$3K ﹤0.01%
+144
New +$1.61K
GERN icon
1230
Geron
GERN
$930M
$3K ﹤0.01%
1,407
HCM icon
1231
HUTCHMED
HCM
$1.93B
$3K ﹤0.01%
185
KURA icon
1232
Kura Oncology
KURA
$826M
$3K ﹤0.01%
227
MRVI icon
1233
Maravai LifeSciences
MRVI
$1.01B
$3K ﹤0.01%
490
OABI icon
1234
OmniAb
OABI
$286M
$3K ﹤0.01%
+475
New +$2.34K
OLMA icon
1235
Olema Pharmaceuticals
OLMA
$1.01B
$3K ﹤0.01%
+224
New +$3.01K
RAPT
1236
DELISTED
RAPT Therapeutics
RAPT
$3K ﹤0.01%
13
RGNX icon
1237
Regenxbio
RGNX
$615M
$3K ﹤0.01%
146
SANA icon
1238
Sana Biotechnology
SANA
$916M
$3K ﹤0.01%
767
SLRN
1239
DELISTED
ACELYRIN
SLRN
$3K ﹤0.01%
+398
New +$3.4K
SVRA icon
1240
Savara
SVRA
$1.09B
$3K ﹤0.01%
+553
New +$2.12K
VERA icon
1241
Vera Therapeutics
VERA
$2.39B
$3K ﹤0.01%
+182
New +$2.31K
ZNTL icon
1242
Zentalis Pharmaceuticals
ZNTL
$329M
$3K ﹤0.01%
212
ZYME icon
1243
Zymeworks
ZYME
$1.66B
$3K ﹤0.01%
+286
New +$2.28K
RVNC
1244
DELISTED
Revance Therapeutics, Inc.
RVNC
$3K ﹤0.01%
331
ICVX
1245
DELISTED
Icosavax, Inc. Common Stock
ICVX
$3K ﹤0.01%
+205
New +$1.97K
ALEC icon
1246
Alector
ALEC
$169M
$2K ﹤0.01%
277
ALXO icon
1247
ALX Oncology
ALXO
$268M
$2K ﹤0.01%
138
ANAB icon
1248
AnaptysBio
ANAB
$1.54B
$2K ﹤0.01%
105
BCYC
1249
Bicycle Therapeutics
BCYC
$275M
$2K ﹤0.01%
103
BMEA icon
1250
Biomea Fusion
BMEA
$90.4M
$2K ﹤0.01%
109

Similar funds

Daiwa Securities Group's Q4 2023 Portfolio in Review

As of Q4 2023, Daiwa Securities Group held 1,426 positions worth $16.1B, up 15% from $14B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Daiwa Securities Group's Q4 2023 filing shows 99 new, 660 increased, 349 reduced and 106 closed positions. Its largest new stake was Veralto: 45,224 shares worth $3.72M. The largest sale was Mid-America Apartment Communities, an estimated $128M.

By sector, the portfolio is most concentrated in Real Estate at 52% of assets, down from 53% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q4 2023 buy was Veralto: 45,224 shares worth $3.72M.
  • Daiwa Securities Group added most to Iron Mountain in Q4 2023, an estimated $97M increase.
  • Daiwa Securities Group's biggest Q4 2023 reduction was Mid-America Apartment Communities, cutting an estimated $128M.
  • Daiwa Securities Group fully exited Activision Blizzard in Q4 2023, selling an estimated $6.04M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $16.1B portfolio in Q4 2023.
  • Daiwa Securities Group opened 99 new positions and closed 106 in Q4 2023.
  • Daiwa Securities Group's portfolio value rose 15% quarter-over-quarter to $16.1B.

Based on Daiwa Securities Group's 13F filing for Q4 2023, filed 31 Jan 2024.